Target intelligence / Profile preview

Dendritic cell (antigen-presenting) (DC (full context: antigen-presenting dendritic cell))

Target
DC (full context: antigen-presenting dendritic cell)
Molecular classification
Professional antigen-presenting cell, Immune system cell type
01

Overview

Dendritic cells are a heterogeneous group of professional antigen-presenting cells present in tissues throughout the body[1][2][3][4]. They capture, process, and display antigens to T lymphocytes via MHC molecules, serving as sentinels that bridge innate and adaptive immunity. Dendritic cells play an essential role in initiating immune responses, maintaining tolerance to self-antigens, and secreting cytokines/chemokines that coordinate immune responses. Their activity is crucial for effective immunity against pathogens and tumors, but also for regulating inflammation and preventing autoimmunity[1][2][3][4][5].

Other names
Dendritic cellDCProfessional antigen-presenting cellAntigen-presenting cell (APC)
02

Mechanism of action

Drugs that affect dendritic cells usually work by: - Promoting differentiation or expansion of DCs (e.g., cytokines) - Enhancing antigen presentation (e.g., vaccine adjuvants) - Modulating DC activation/maturation state (immunotherapies) - Inducing DC-mediated immune tolerance (investigational approaches)

03

Biological functions

Antigen processingAntigen presentation (via MHC class I and II)T cell activation and differentiationCytokine and chemokine secretionBridging innate and adaptive immunityInduction/maintenance of immune tolerance
04

Disease associations

Infection (bacterial, viral, fungal)Cancer (immunity and tumor tolerance)InflammationAutoimmunity (tolerance and dysregulation)Allergic diseaseOther immune system disorders
05

Safety considerations

Overactivation can lead to unwanted inflammation or autoimmunity.Dysfunction or depletion may cause immunodeficiency or increased infection risk.Manipulation in cell therapy (e.g., DC vaccines) requires rigorous ex vivo handling for safety.
06

Interacting drugs

GM-CSF (granulocyte-macrophage colony stimulating factor)

3 more in the full profile.

07

Biomarkers

CD11cHLA-DRCD1c, CD141 (subset-specific)CD123, BDCA-2 (plasmacytoid DCs)

Beyond the preview

Go deeper on Dendritic cell (antigen-presenting) (DC (full context: antigen-presenting dendritic cell)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic cell (antigen-presenting) (DC (full context: antigen-presenting dendritic cell)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call